Jerry S Wolinsky

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 31

Top Topics

Magnetic Resonance

Top Venues

Multiple sclerosis (Houndmills, Basingstoke, England)

Annals of clinical and translational neurology

Multiple sclerosis journal - experimental, translational and clinical

This page only lists publications with an associated author ORCID identifier.

Publications

Xavier Montalban, Karolina Piasecka-Stryczynska, Jens Kuhle, Pascal Benkert, Douglas Lorne Arnold, Martin S Weber, Andrea Seitzinger, Hans Guehring, Jamie Shaw, Davorka Tomic, Yann Hyvert, Danielle E Harlow, Martin Dyroff, Jerry S Wolinsky
Efficacy and safety results after >3.5 years of treatment with the Bruton's tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (4-5) (2024)
Xavier Montalban, Karolina Piasecka-Stryczynska, Jens Kuhle, Pascal Benkert, Douglas Lorne Arnold, Martin S Weber, Andrea Seitzinger, Hans Guehring, Jamie Shaw, Davorka Tomic, Yann Hyvert, Danielle E Harlow, Martin Dyroff, Jerry S Wolinsky
Efficacy and safety results after >3.5 years of treatment with the Bruton's tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (4-5) (2024)
Kaarina Kowalec, Arvid Harder, Casandra Dolovich, Kathryn C Fitzgerald, Salter Amber, Yi Lu, Charles N Bernstein, James M Bolton, Gary Cutter, John D Fisk, Joel Gelernter, Lesley A Graff, Sara Hägg, Carol A Hitchon, Daniel F Levey, Fred D Lublin, Kyla A McKay, Scott Patten, Amit Patki, Murray B Stein, Hemant K Tiwari, Jerry S Wolinsky, Ruth A Marrie
Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis. Annals of clinical and translational neurology 11 (6) (2024)
Kaarina Kowalec, Arvid Harder, Casandra Dolovich, Kathryn C Fitzgerald, Salter Amber, Yi Lu, Charles N Bernstein, James M Bolton, Gary Cutter, John D Fisk, Joel Gelernter, Lesley A Graff, Sara Hägg, Carol A Hitchon, Daniel F Levey, Fred D Lublin, Kyla A McKay, Scott Patten, Amit Patki, Murray B Stein, Hemant K Tiwari, Jerry S Wolinsky, Ruth A Marrie
Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis. Annals of clinical and translational neurology 11 (6) (2024)
Kaarina Kowalec, Arvid Harder, Casandra Dolovich, Kathryn C Fitzgerald, Salter Amber, Yi Lu, Charles N Bernstein, James M Bolton, Gary Cutter, John D Fisk, Joel Gelernter, Lesley A Graff, Sara Hägg, Carol A Hitchon, Daniel F Levey, Fred D Lublin, Kyla A McKay, Scott Patten, Amit Patki, Murray B Stein, Hemant K Tiwari, Jerry S Wolinsky, Ruth A Marrie
Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis. Annals of clinical and translational neurology (2024)
Xavier Montalban, Karolina Piasecka-Stryczynska, Jens Kuhle, Pascal Benkert, Douglas Lorne Arnold, Martin S Weber, Andrea Seitzinger, Hans Guehring, Jamie Shaw, Davorka Tomic, Yann Hyvert, Danielle E Harlow, Martin Dyroff, Jerry S Wolinsky
Efficacy and safety results after >3.5 years of treatment with the Bruton's tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (4-5) (2024)
Xavier Montalban, Karolina Piasecka-Stryczynska, Jens Kuhle, Pascal Benkert, Douglas Lorne Arnold, Martin S Weber, Andrea Seitzinger, Hans Guehring, Jamie Shaw, Davorka Tomic, Yann Hyvert, Danielle E Harlow, Martin Dyroff, Jerry S Wolinsky
Efficacy and safety results after >3.5 years of treatment with the Bruton's tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study. Multiple sclerosis (Houndmills, Basingstoke, England) (2024)
Xavier Montalban, Karolina Piasecka-Stryczynska, Jens Kuhle, Pascal Benkert, Douglas Lorne Arnold, Martin S Weber, Andrea Seitzinger, Hans Guehring, Jamie Shaw, Davorka Tomic, Yann Hyvert, Danielle E Harlow, Martin Dyroff, Jerry S Wolinsky
Efficacy and safety results after >3.5 years of treatment with the Bruton's tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (4-5) (2024)
Kaarina Kowalec, Arvid Harder, Casandra Dolovich, Kathryn C Fitzgerald, Salter Amber, Yi Lu, Charles N Bernstein, James M Bolton, Gary Cutter, John D Fisk, Joel Gelernter, Lesley A Graff, Sara Hägg, Carol A Hitchon, Daniel F Levey, Fred D Lublin, Kyla A McKay, Scott Patten, Amit Patki, Murray B Stein, Hemant K Tiwari, Jerry S Wolinsky, Ruth A Marrie
Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis. Annals of clinical and translational neurology 11 (6) (2024)
Gary R Cutter, Richard A Rudick, Carl de Moor, Carol M Singh, Elizabeth Fisher, Thijs Koster, Fred D Lublin, Jerry S Wolinsky, Henry McFarland, Steven Jacobson, Maria L Naylor
Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trial. Multiple sclerosis journal - experimental, translational and clinical 9 (2) (2023)
Sammita Satyanarayan, Gary R Cutter, Stephen Krieger, Stacey Cofield, Jerry S Wolinsky, Fred Lublin
The impact of relapse definition and measures of durability on MS clinical trial outcomes. Multiple sclerosis (Houndmills, Basingstoke, England) 29 (4-5) (2023)
Sammita Satyanarayan, Gary R Cutter, Stephen Krieger, Stacey Cofield, Jerry S Wolinsky, Fred Lublin
The impact of relapse definition and measures of durability on MS clinical trial outcomes. Multiple sclerosis (Houndmills, Basingstoke, England) 29 (4-5) (2023)
Gary R Cutter, Richard A Rudick, Carl de Moor, Carol M Singh, Elizabeth Fisher, Thijs Koster, Fred D Lublin, Jerry S Wolinsky, Henry McFarland, Steven Jacobson, Maria L Naylor
Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trial. Multiple sclerosis journal - experimental, translational and clinical 9 (2) (2023)
Kaarina Kowalec, Kathryn C Fitzgerald, Salter Amber, Casandra Dolovich, Arvid Harder, Charles N Bernstein, James Bolton, Gary R Cutter, Lesley A Graff, Sara Hägg, Carol Ann Hitchon, Yi Lu, Fred Lublin, Kyla A McKay, Scott Burton Patten, Amit Patki, Hemant K Tiwari, Jerry S Wolinsky, Ruth Ann Marrie
Polygenicity of Comorbid Depression in Multiple Sclerosis. Neurology (2023)
Marcus Werner Koch, Ester Moral, Luis Brieva, Jop Mostert, Eva M M Strijbis, Jacynthe Comtois, Pavle Repovic, James D Bowen, Jerry S Wolinsky, Fred D Lublin, Gary R Cutter
Relapse recovery in relapsing-remitting multiple sclerosis: An analysis of the CombiRx dataset. Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Sammita Satyanarayan, Gary R Cutter, Stephen Krieger, Stacey Cofield, Jerry S Wolinsky, Fred Lublin
The impact of relapse definition and measures of durability on MS clinical trial outcomes. Multiple sclerosis (Houndmills, Basingstoke, England) 29 (4-5) (2023)
Douglas Lorne Arnold, Till Sprenger, Amit Bar-Or, Jerry S Wolinsky, Ludwig Kappos, Shannon Kolind, Ulrike Bonati, Stefano Magon, Johan van Beek, Harold Koendgen, Oscar Bortolami, Corrado Bernasconi, Laura Gaetano, Anthony Traboulsee
Ocrelizumab reduces thalamic volume loss in patients with RMS and PPMS. Multiple sclerosis (Houndmills, Basingstoke, England) 28 (12) (2022)
Eleni S Vasileiou, Chen Hu, Charles N Bernstein, Fred Lublin, Jerry S Wolinsky, Gary R Cutter, Elias S Sotirchos, Kaarina Kowalec, Salter Amber, Shiv Saidha, Ellen M Mowry, Peter A Calabresi, Ruth Ann Marrie, Kathryn C Fitzgerald
Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis. Neurology(R) neuroimmunology & neuroinflammation 10 (1) (2022)
Corey C Ford, Jeffrey A Cohen, Andrew D Goodman, J William Lindsey, Robert P Lisak, Christopher Luzzio, Amy Pruitt, John Rose, Horea Rus, Jerry S Wolinsky, Shaul E Kadosh, Emily Bernstein-Hanlon, Yafit Stark, Jessica K Alexander
Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension study. Multiple sclerosis (Houndmills, Basingstoke, England) 28 (11) (2022)
Bianca Weinstock-Guttman, Robert A Bermel, Gary Cutter, Mark S Freedman, Thomas P Leist, Xiaoye Ma, Deidre Kile, Bruno Musch, Anthony T Reder, Jerry S Wolinsky
Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trial. Multiple sclerosis (Houndmills, Basingstoke, England) (2021)
Marcus Werner Koch, Jop Mostert, Yinan Zhang, Jerry S Wolinsky, Fred D Lublin, Eva Strijbis, Gary Cutter
Association of Age With Contrast-Enhancing Lesions Across the Multiple Sclerosis Disease Spectrum. Neurology 97 (13) (2021)
Stephen L Hauser, Ludwig Kappos, Xavier Montalban, Licinio Craveiro, Cathy Chognot, Richard Hughes, Harold Koendgen, Noemi Pasquarelli, Ashish Pradhan, Kalpesh Prajapati, Jerry S Wolinsky
Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis. Neurology 97 (16) (2021)
Marcus W Koch, Jop P Mostert, Jerry S Wolinsky, Fred D Lublin, Bernard Uitdehaag, Gary R Cutter
Comparison of the EDSS, Timed 25-Foot Walk, and the 9-Hole Peg Test as Clinical Trial Outcomes in Relapsing-Remitting Multiple Sclerosis. Neurology 97 (16) (2021)
Francesca Bovis, Tomas Kalincik, Fred Lublin, Gary Cutter, Charles Malpas, Dana Horakova, Eva Kubala Havrdova, Maria Trojano, Alexandre Prat, Marc Girard, Pierre Duquette, Marco Onofrj, Alessandra Lugaresi, Guillermo Izquierdo, Sara Eichau, Francesco Patti, Murat Terzi, Pierre Grammond, Roberto Bergamaschi, Patrizia Sola, Diana Ferraro, Serkan Ozakbas, Gerardo Iuliano, Cavit Boz, Raymond Hupperts, Francois Grand'Maison, Celia Oreja-Guevara, Vincent van Pesch, Elisabetta Cartechini, Thor Petersen, Ayse Altintas, Aysun Soysal, Cristina Ramo-Tello, Pamela McCombe, Recai Turkoglu, Helmut Butzkueven, Jerry S Wolinsky, Claudio Marcello Solaro, Maria Pia Sormani
Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a. Neurology 96 (2) (2020)
Tanuja Chitinis, Brenda Banwell, Lauren B Krupp, Douglas L Arnold, Amit Bar-Or, Wolfgang Brück, Gavin Giovannoni, Benjamin Greenberg, Angelo Ghezzi, Emmanuelle Waubant, Kevin Rostasy, Kumaran Deiva, Peter Huppke, Jerry S Wolinsky, Ying Zhang, Amin Azmon, Annik K-Laflamme, Rajesh Karan, Jutta Gärtner
Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy in paediatric patients with multiple sclerosis: Results from the PARADIGMS study. Multiple sclerosis (Houndmills, Basingstoke, England) 27 (6) (2020)
Jerry S Wolinsky, Natalie J Engmann, Jinglan Pei, Ashish Pradhan, Clyde Markowitz, Edward J Fox
An exploratory analysis of the efficacy of ocrelizumab in patients with multiple sclerosis with increased disability. Multiple sclerosis journal - experimental, translational and clinical 6 (1) (2020)
Robert T Naismith, Jerry S Wolinsky, Annette Wundes, Christopher LaGanke, Douglas L Arnold, Dragana Obradovic, Mark S Freedman, Mark Gudesblatt, Tjalf Ziemssen, Boris Kandinov, Ilda Bidollari, Maria Lopez-Bresnahan, Narinder Nangia, David Rezendes, Lili Yang, Hailu Chen, Shifang Liu, Jerome Hanna, Catherine Miller, Richard Leigh-Pemberton
Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study. Multiple sclerosis (Houndmills, Basingstoke, England) 26 (13) (2019)
Refaat E Gabr, Ivan Coronado, Melvin Robinson, Sheeba J Sujit, Sushmita Datta, Xiaojun Sun, William J Allen, Fred D Lublin, Jerry S Wolinsky, Ponnada A Narayana
Brain and lesion segmentation in multiple sclerosis using fully convolutional neural networks: A large-scale study. Multiple sclerosis (Houndmills, Basingstoke, England) 26 (10) (2019)
Ponnada A Narayana, Ivan Coronado, Sheeba J Sujit, Jerry S Wolinsky, Fred D Lublin, Refaat E Gabr
Deep Learning for Predicting Enhancing Lesions in Multiple Sclerosis from Noncontrast MRI. Radiology 294 (2) (2019)
Colm Elliott, Jerry S Wolinsky, Stephen L Hauser, Ludwig Kappos, Frederik Barkhof, Corrado Bernasconi, Wei Wei, Shibeshih Belachew, Douglas L Arnold
Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions. Multiple sclerosis (Houndmills, Basingstoke, England) 25 (14) (2018)
Edward J Fox, Clyde Markowitz, Angela Applebee, Xavier Montalban, Jerry S Wolinsky, Shibeshih Belachew, Damian Fiore, Jinglan Pei, Bruno Musch, Gavin Giovannoni
Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial. Multiple sclerosis (Houndmills, Basingstoke, England) 24 (14) (2018)